HeatherDaltonMD

Gynecologic Oncology

Dr. Dalton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2012 - 2016
Creighton University School of Medicine (Phoenix)Residency, Obstetrics and Gynecology, 2008 - 2012
University of South Carolina School of MedicineClass of 2008

PubMed

6 citations
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Leslie M Randall, David M O'Malley, Bradley J Monk, Robert L Coleman, Stephanie Gaillard
Gynecologic Oncology. 2023-11-01
Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer.
Ju Won Roh, Jie Huang, Wei Hu, Xiao Yun Yang, Nicholas B. Jennings
Clinical Cancer Research. 2021-08-01
2 citations
Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.
Rajesha Rupaimoole, Sherry Y. Wu, Sunila Pradeep, Cristina Ivan, Chad V. Pecot
Nature Communications. 2020-06-03

Amid PARP Advances, Chemo Remains Critical in Ovarian CancerApril 11th, 2017
Doctors: Risk of Death from Cervical Cancer Higher Than We ThoughtJanuary 26th, 2017
Cervical Cancer Mortality Rates May Be UnderestimatedJanuary 23rd, 2017
Join now to see all